Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127906051 | 12790605 | 1 | I | 2016 | 20160725 | 20160929 | 20160929 | PER | US-TEVA-680743USA | TEVA | 40.00 | YR | F | Y | 50.00000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127906051 | 12790605 | 1 | PS | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Unknown | 5 MILLIGRAM DAILY; | U | 74421 | 5 | MG | TABLET | QD | |||||
| 127906051 | 12790605 | 2 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MILLIGRAM DAILY; | U | 0 | 40 | MG | TABLET | QD | |||||
| 127906051 | 12790605 | 3 | SS | HYDROCODONE | HYDROCODONE | 1 | Unknown | U | 0 | 7.5 | MG | ||||||||
| 127906051 | 12790605 | 4 | SS | LETROZOLE. | LETROZOLE | 1 | Unknown | U | 0 | TABLET | QD | ||||||||
| 127906051 | 12790605 | 5 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | 50 | MG | TABLET | |||||||
| 127906051 | 12790605 | 6 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | U | 0 | ||||||||||
| 127906051 | 12790605 | 7 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0 | 1 | MG | TABLET | ||||||||
| 127906051 | 12790605 | 8 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | 0 | TID | ||||||||||
| 127906051 | 12790605 | 9 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 4 MILLIGRAM DAILY; | 0 | 1 | MG | TABLET | QID | ||||||
| 127906051 | 12790605 | 10 | SS | OXYCODONE | OXYCODONE | 1 | Oral | 10/325 MG Q6HR | 0 | ||||||||||
| 127906051 | 12790605 | 11 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | M91202 | 0 | CAPSULE | QD | ||||||||
| 127906051 | 12790605 | 12 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | |||||||||
| 127906051 | 12790605 | 13 | SS | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Unknown | 0 | 25 | MG | TABLET | ||||||||
| 127906051 | 12790605 | 14 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
| 127906051 | 12790605 | 15 | C | Multivitamin | VITAMINS | 1 | Unknown | 0 | |||||||||||
| 127906051 | 12790605 | 16 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127906051 | 12790605 | 1 | Product used for unknown indication |
| 127906051 | 12790605 | 2 | Gastrooesophageal reflux disease |
| 127906051 | 12790605 | 3 | Pain |
| 127906051 | 12790605 | 4 | Breast cancer |
| 127906051 | 12790605 | 5 | Sleep disorder |
| 127906051 | 12790605 | 6 | Blood pressure abnormal |
| 127906051 | 12790605 | 7 | Anxiety |
| 127906051 | 12790605 | 8 | Pain |
| 127906051 | 12790605 | 9 | Anxiety |
| 127906051 | 12790605 | 10 | Pain |
| 127906051 | 12790605 | 11 | Breast cancer |
| 127906051 | 12790605 | 12 | Pain |
| 127906051 | 12790605 | 13 | Nausea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127906051 | 12790605 | Asthenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127906051 | 12790605 | 3 | 2016 | 0 | ||
| 127906051 | 12790605 | 8 | 2016 | 0 | ||
| 127906051 | 12790605 | 11 | 2016 | 0 |